AAAAAA
Results:
1-12
|
Results: 12
Authors:
Ree, AH
Engerbraaten, O
Hovig, E
Fodstad, O
Citation: Ah. Ree et al., Differential display analysis of breast carcinoma cells enriched by immunomagnetic target cell selection: Gene expression profiles in bone marrow target cells, INT J CANC, 97(1), 2002, pp. 28-33
Authors:
Hovig, E
Maelandsmo, G
Mellingsaeter, T
Fodstad, O
Mielewczyk, SS
Wolfe, J
Goodchild, J
Citation: E. Hovig et al., Optimization of hammerhead ribozymes for the cleavage of S100A4 (CAPL) mRNA, ANTISENSE N, 11(2), 2001, pp. 67-75
Authors:
Jenssen, TK
Laegreid, A
Komorowski, J
Hovig, E
Citation: Tk. Jenssen et al., A literature network of human genes for high-throughput analysis of gene expression, NAT GENET, 28(1), 2001, pp. 21
Authors:
Moller, P
Borg, A
Heimdal, K
Apold, J
Vallon-Christersson, J
Hovig, E
Maehle, L
Citation: P. Moller et al., The BRCA1 syndrome and other inherited breast or breast-ovarian cancers ina Norwegian prospective series, EUR J CANC, 37(8), 2001, pp. 1027-1032
Authors:
Moller, P
Heimdal, K
Apold, J
Fredriksen, A
Borg, A
Hovig, E
Hagen, A
Hagen, B
Pedersen, JC
Maehle, L
Citation: P. Moller et al., Genetic epidemiology of BRCA1 mutations in Norway, EUR J CANC, 37(18), 2001, pp. 2428-2434
Authors:
Dorum, A
Hovig, E
Trope, C
Inganas, M
Moller, P
Citation: A. Dorum et al., Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA, EUR J CANC, 35(5), 1999, pp. 779-781
Authors:
Wacey, AI
Cooper, DN
Liney, D
Hovig, E
Krawczak, M
Citation: Ai. Wacey et al., Disentangling the perturbational effects of amino acid substitutions in the DNA-binding domain of p53, HUM GENET, 104(1), 1999, pp. 15-22
Authors:
Borg, A
Dorum, A
Heimdal, K
Maehle, L
Hovig, E
Moller, P
Citation: A. Borg et al., BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations, DIS MARKER, 15(1-3), 1999, pp. 79-84
Authors:
Ree, AH
Tvermyr, M
Engebraaten, O
Rooman, M
Rosok, O
Hovig, E
Meza-Zepeda, LA
Bruland, OS
Fodstad, O
Citation: Ah. Ree et al., Expression of a novel factor in human breast cancer cells with metastatic potential, CANCER RES, 59(18), 1999, pp. 4675-4680
Authors:
Bjornland, K
Winberg, JO
Odegaard, OT
Hovig, E
Loennechen, T
Aasen, AO
Fodstad, O
Maelandsmo, GM
Citation: K. Bjornland et al., S100A4 involvement in metastasis: Deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme, CANCER RES, 59(18), 1999, pp. 4702-4708
Authors:
Dorum, A
Heimdal, K
Hovig, E
Inganas, M
Moller, P
Citation: A. Dorum et al., Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer, AM J HU GEN, 65(3), 1999, pp. 671-679
Authors:
Andersen, K
Maelandsmo, GM
Hovig, E
Fodstad, O
Loennechen, T
Winberg, JO
Citation: K. Andersen et al., Interleukin-1 alpha and basic fibroblast growth factor induction of matrixmetalloproteinases and their inhibitors in osteosarcoma cells is modulatedby the metastasis associated protein CAPL, ANTICANC R, 18(5A), 1998, pp. 3299-3303
Risultati:
1-12
|